Clomid Side Effects in Men: Mood, Vision, Estradiol and Libido

Clomid is approved for women, but urologists have prescribed it to men with low testosterone or low sperm counts for decades. A 2019 review by Wheeler and colleagues in Sexual Medicine Reviews dates its use in men to the 1970s. The FDA label covers only women, so the numbers for Clomid side effects in men come from published studies rather than the label.

Those studies give a wide range, depending on how carefully side effects were recorded:

Taken together, the studies show that serious side effects are rare, while milder ones such as lower libido or mood changes are more common than early studies suggested when doctors ask about them directly. This guide covers each one and what the numbers show. For how the drug works in men, see our Clomid for men page.

Mood changes are the side effect men mention most often. In the Krzastek study of 400 men, changes in mood were the most common complaint, followed by blurred vision and breast tenderness. The 2019 Wheeler review lists "psychiatric exacerbation" among the uncommon effects, meaning a worsening of existing anxiety or depression.

The Saffati study asked more specific questions and found higher rates in men on clomiphene:

Lower libido stands out. A third of men on clomiphene in that study reported it, even though testosterone rose. An earlier comparison by Ramasamy and colleagues (Journal of Urology, 2014) found that overall satisfaction was similar on clomiphene and testosterone, but libido scores were higher with testosterone injections than with clomiphene (4 vs 3 on the questionnaire used).

One likely reason is zuclomiphene, the long-acting isomer in Clomid, which has partly estrogen-like effects. The next section explains why estradiol matters here. Men who get these symptoms often ask about enclomiphene vs Clomid, since the single isomer was developed to avoid them.

Clomid raises testosterone by raising LH, and some of that extra testosterone converts to estradiol. On top of that, zuclomiphene acts partly like estrogen. The combined result is that estradiol usually rises.

The numbers are consistent across studies. In a study by Helo and colleagues (BJU International, 2017), 15 men on Clomid 25 mg daily for a median of about 26 months saw estradiol double, from 17 to 34 pg/mL, while testosterone went from 205 to 488 ng/dL. The Krzastek study also reported a significant rise in estradiol. In the Saffati study, estradiol rose by an average of 17.5 pg/mL on clomiphene.

Helo's team also measured the two isomers. The median zuclomiphene level was 44.0 ng/mL against 2.2 ng/mL of enclomiphene, a ratio of about 20 to 1. After months of daily use, most of the drug in the blood was the estrogen-like isomer.

Breast tenderness and gynecomastia follow from this. Breast tenderness was among the most common complaints in the Krzastek study, gynecomastia appeared in 3% of men on clomiphene in the Saffati study, and the FDA label itself notes that "testicular tumors and gynecomastia have been reported in males using clomiphene." Checking estradiol on follow-up labs, not only testosterone, is the way to catch this early.

Visual side effects are the most serious risk of Clomid. The FDA label warns that blurring, spots or flashes can occur and that "the visual disturbances may be irreversible, especially with increased dosage or duration of therapy." In the label's data from women, visual symptoms were reported by 1.5% of patients.

In men, blurred vision was the second most common side effect in the Krzastek study of 400 men. There is also a published case report by Alizadeh and colleagues (International Journal of Reproductive BioMedicine, 2021) of a 33-year-old man who took 100 mg daily for fertility. On day 14 he had a sudden drop in vision in his right eye, followed by loss of part of his visual field, which the authors attributed to optic neuropathy. That dose is two to four times higher than the 25 to 50 mg used in most male studies.

The practical rule is simple. Any new blurring, flashes of light, spots or loss of part of the visual field while on Clomid means stopping the drug and seeing an eye doctor promptly. Men who already have eye disease should mention it before starting. Our Clomid side effects page covers the visual warning in full.

Some effects that worry men on testosterone therapy are less of a concern with Clomid. The clearest example is red blood cell count. A 2017 study by Wheeler and colleagues (Journal of Urology) compared 188 men on clomiphene with 175 men on testosterone. Polycythemia, an abnormally high red cell count, occurred in 1.7% of men on clomiphene and 11.2% of men on testosterone.

Long-term studies are reassuring on safety. Moskovic and colleagues (BJU International, 2012) followed 46 men for up to 3 years: testosterone rose from 228 ng/dL to 612, 562 and 582 ng/dL at years 1, 2 and 3, bone density at the hip and spine improved, and no adverse events were reported. In the Krzastek study, 120 men had been on clomiphene for more than 3 years, with results no different from shorter use and no significant adverse events.

Not every study found symptom benefit, even without side effects. A 2025 Japanese study by Anno and colleagues (International Journal of Urology) gave 54 men 50 mg every other day for a year. Testosterone rose and no adverse events occurred, but sexual symptoms did not improve significantly.

Most studies in men used lower and more frequent doses than the fertility schedule for women. Common regimens include 25 mg daily, raised to 50 mg daily if needed (Katz 2012, where 70% ended on 25 mg), and 50 mg every other day (Anno 2025). The case of optic neuropathy occurred at 100 mg daily.

Ways to lower the risk, based on the studies above:

Men using Clomid after a steroid cycle face a different set of questions, covered in our Clomid PCT guide. For the newer isomer, see enclomiphene side effects.

Clomid.org is an independent educational resource. We are not affiliated with any pharmaceutical manufacturer, compounding pharmacy, telehealth company or healthcare provider. This content is for informational purposes only and does not constitute medical advice. Images on this site are illustrative artwork made for editorial purposes; they do not show real products, packaging or labels and are not an advertisement or an offer to sell.